Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

HelloWellness Tirzepatide Review: Cost, a LegitScript Domain Mismatch & Honest Verdict (2026)

An honest 2026 review of HelloWellness tirzepatide — a low starting price, a 3-month minimum, and a LegitScript seal for a different domain.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Telos Rx

Compounded injectable, oral, and microdosed tirzepatide from a LegitScript-certified telehealth, with a low annual entry price.

From $139/mo (plan-length dependent)

Check Telos Rx availability

This review attempted to independently verify HelloWellness directly against hellowellness.health and could not: the site redirected to a CAPTCHA challenge page, blocking automated verification. Worth flagging directly before anything else: the site's LegitScript seal is issued for a related but different domain, hellowellness.ai — not hellowellness.health, the site actually reviewed here.

A LegitScript seal for a different domain — worth confirming

This is the most important thing to check before trusting HelloWellness's accreditation badge: the LegitScript seal displayed on hellowellness.health actually verifies hellowellness.ai — a related but technically different domain. This may simply reflect a shared corporate parent, but it's not a like-for-like match, and this review's live pass couldn't confirm the relationship given the site was blocked. Confirm directly that the two domains are operated by the same entity before treating the badge as verification of the site you're actually using.

Live verification was blocked

This review attempted to independently confirm HelloWellness's current pricing and program details directly against hellowellness.health. The connection redirected to a CAPTCHA challenge page, the same anti-bot pattern encountered on other providers reviewed on this site. Every figure below was last verified on July 20, 2026.

§ HelloWellness — The Domain Mismatch

ItemStatus
Site reviewedhellowellness.health
LegitScript seal verifieshellowellness.ai — a different domain
Live verificationBlocked — CAPTCHA redirect
This review's live verification attempt was blocked by a CAPTCHA redirect.

What HelloWellness is

HelloWellness (hellowellness.health) is a compounded GLP-1 telehealth platform, offering compounded semaglutide starting at $133/month and tirzepatide starting at $166/month — among the cheapest starting prices in this category — with a 3-month minimum plan. Every shipment includes syringes, needles, and injection instructions, and a private Facebook community offers patient support.

The brand-vs-compounded question

HelloWellness dispenses compounded tirzepatide only. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

HelloWellness's real strengths: among the cheapest starting prices in this category, a clearly stated cancel-anytime-after-3-months policy, and syringes, needles, and instructions included with every shipment. The trade-offs are significant: the 3-month minimum means you pay for all three months even if you stop early, the LegitScript seal verifies a different domain (hellowellness.ai, not hellowellness.health), the parent company isn't disclosed, states served aren't listed, and pharmacy partners aren't named. This review's own attempt to verify any of it live was also blocked by a CAPTCHA wall. As with any GLP-1 program, and especially one with an accreditation badge pointing to a different domain, confirm the corporate relationship directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

HelloWellness's low starting price is genuine but the LegitScript seal pointing to a different domain than the one you'd actually sign up on is worth resolving directly before trusting it as verification, and this review couldn't reach the site live to check further. For a provider with an accreditation badge that matches its own domain, compare it against Harbor or BiltRx. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through HelloWellness?

Starting at $166/month, with a 3-month minimum commitment. This review could not independently reconfirm this live; hellowellness.health is blocked by a CAPTCHA wall.

Is HelloWellness's LegitScript seal for the site I'd sign up on?

Not exactly — the displayed seal verifies hellowellness.ai, a related but different domain than hellowellness.health, the site actually reviewed. Confirm the corporate relationship directly.

Can I cancel HelloWellness anytime?

Yes, but only after a 3-month minimum — you pay for all three months even if you stop early.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related monograph sections

View all sections